New polio vaccine poised to get emergency WHO approval.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.Lancet (London, England) · 2021
   Trial
2. Physicochemical properties and adsorption state of aluminum adjuvants with different processes in vaccines.Heliyon · 2023
   Article
3. Re-emergence of vaccine-derived poliovirus in Israel, US, and UK - Call for promoting the use of novel oral polio vaccine.Annals of medicine and surgery (2012) · 2022
   Article
4. Polio outbreaks in the post-COVID-19 pandemic era: causes and solutions.Pathogens and global health
   Review

Corrections and comments

• Comment on
  Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence.2020

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as